Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Impact of Orthoclone OKT3 on liver transplantation.

Literature DB >> 3105139

Impact of Orthoclone OKT3 on liver transplantation.

J J Fung, B H Markus, R D Gordon, C O Esquivel, L Makowka, A Tzakis, T E Starzl.

Abstract

Mesh：

Substances：

Year: 1987 PMID： 3105139 PMCID： PMC2943668

Source DB: PubMed Journal: Transplant Proc ISSN： 0041-1345 Impact factor: 1.066

× No keyword cloud information.

7 in total

1. ORTHOCLONE OKT3 in Treatment of Allografts Rejected Under Cyclosporine-Steroid Therapy.

Authors: T E Starzl; J J Fung
Journal: Transplant Proc Date: 1986-08 Impact factor: 1.066

2. A randomized clinical trial comparing OKT3 and steroids for treatment of hepatic allograft rejection.

Authors: A B Cosimi; S I Cho; F L Delmonico; M M Kaplan; R J Rohrer; R L Jenkins
Journal: Transplantation Date: 1987-01 Impact factor: 4.939

3. Retransplantation of the liver.

Authors: B W Shaw; R D Gordon; S Iwatsuki; T E Starzl
Journal: Semin Liver Dis Date: 1985-11 Impact factor: 6.115

4. Current status of hepatic transplantation.

Authors: S Iwatsuki; B W Shaw; T E Starzl
Journal: Semin Liver Dis Date: 1983-08 Impact factor: 6.115

5. Treatment of acute renal allograft rejection with OKT3 monoclonal antibody.

Authors: A B Cosimi; R C Burton; R B Colvin; G Goldstein; F L Delmonico; M P LaQuaglia; N Tolkoff-Rubin; R H Rubin; J T Herrin; P S Russell
Journal: Transplantation Date: 1981-12 Impact factor: 4.939

6. A randomized clinical trial of OKT3 monoclonal antibody for acute rejection of cadaveric renal transplants.

Authors:
Journal: N Engl J Med Date: 1985-08-08 Impact factor: 91.245

7. Influence of selected patient variables and operative blood loss on six-month survival following liver transplantation.

Authors: B W Shaw; R P Wood; R D Gordon; S Iwatsuki; W P Gillquist; T E Starzl
Journal: Semin Liver Dis Date: 1985-11 Impact factor: 6.115

7 in total

13 in total

1. Infections in pediatric liver recipients treated for acute rejection.

Authors: B Koneru; V P Scantlebury; L Makowka; C O Esquivel; S Todo; A G Tzakis; J W Marsh; S Iwatsuki; L Douglas; T E Starzl
Journal: Transplant Proc Date: 1989-02 Impact factor: 1.066

Review 2. The role of OKT3 in clinical transplantation.

Authors: D J Norman; M R Leone
Journal: Pediatr Nephrol Date: 1991-01 Impact factor: 3.714

Review 3. The changing face of liver transplantation.

Authors: C Shorrock; J Neuberger
Journal: Gut Date: 1993-03 Impact factor: 23.059

4. Effect of OKT3 on survival and rate of retransplantation.

Authors: B H Markus; J J Fung; R D Gordon; S Iwatsuki; C O Esquivel; L Makowka; T E Starzl
Journal: Transplant Proc Date: 1987-08 Impact factor: 1.066

5. The Denver-Pittsburgh liver transplant series.

Authors: R D Gordon; S Iwatsuki; A G Tzakis; C O Esquivel; S Todo; L Makowka; T E Starzl
Journal: Clin Transpl Date: 1987

6. Histocompatibility and liver transplant outcome. Does HLA exert a dualistic effect?

Authors: B H Markus; R J Duquesnoy; R D Gordon; J J Fung; M Vanek; G Klintmalm; C Bryan; D Van Thiel; T E Starzl
Journal: Transplantation Date: 1988-09 Impact factor: 4.939

Review 7. Muromonab CD3. A review of its pharmacology and therapeutic potential.

Authors: P A Todd; R N Brogden
Journal: Drugs Date: 1989-06 Impact factor: 9.546

8. Treatment of Guillain-Barré syndrome with anti-T cell monoclonal antibodies.

Authors: T E Feasby
Journal: J Neurol Neurosurg Psychiatry Date: 1991-01 Impact factor: 10.154

9. Pseudomonas aeruginosa bacteremia in patients undergoing liver transplantation: an emerging problem.

Authors: J A Korvick; J W Marsh; T E Starzl; V L Yu
Journal: Surgery Date: 1991-01 Impact factor: 3.982

Review 10. Prophylactic use of OKT3 in liver transplantation. A review.

Authors: J Fung; T Starzl
Journal: Dig Dis Sci Date: 1991-10 Impact factor: 3.199